Patents by Inventor Inez A. Ruiz-White

Inez A. Ruiz-White has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230203088
    Abstract: This application is directed to the use of aminosteroid compounds for the selective inhibition of the enzyme PTP1B in a mammal for the treatment of diabetes.
    Type: Application
    Filed: July 29, 2022
    Publication date: June 29, 2023
    Applicant: DepYmed Inc.
    Inventors: Michael McLane, Inez Ruiz-White, W. Lee Maloy, Henry R. Wolfe
  • Patent number: 11434257
    Abstract: This application is directed to the use of aminosteroid compounds for the selective inhibition of the enzyme PTP1B in a mammal for the treatment of diabetes.
    Type: Grant
    Filed: January 30, 2020
    Date of Patent: September 6, 2022
    Assignee: DepYmed Inc.
    Inventors: Michael McLane, Inez Ruiz-White, W. Lee Maloy, Henry R. Wolfe
  • Publication number: 20200270300
    Abstract: This application is directed to the use of aminosteroid compounds for the selective inhibition of the enzyme PTP1B in a mammal for the treatment of diabetes.
    Type: Application
    Filed: January 30, 2020
    Publication date: August 27, 2020
    Applicant: Ohr Pharmaceutical, Inc.
    Inventors: Michael McLane, Inez Ruiz-White, W. Lee Maloy, Henry R. Wolfe
  • Patent number: 10556923
    Abstract: This application is directed to the use of aminosteroid compounds for the selective inhibition of the enzyme PTP1B in a mammal for the treatment of diabetes.
    Type: Grant
    Filed: March 12, 2019
    Date of Patent: February 11, 2020
    Assignee: Ohr Pharmaceutical Inc.
    Inventors: Michael McLane, Inez Ruiz-White, W. Lee Maloy, Henry R. Wolfe
  • Publication number: 20190202858
    Abstract: This application is directed to the use of aminosteroid compounds for the selective inhibition of the enzyme PTP1B in a mammal for the treatment of diabetes.
    Type: Application
    Filed: March 12, 2019
    Publication date: July 4, 2019
    Applicant: Ohr Pharmaceutical, Inc.
    Inventors: Michael McLane, Inez Ruiz-White, W. Lee Maloy, Henry R. Wolfe
  • Publication number: 20170129914
    Abstract: This application is directed to the use of aminosteroid compounds for the selective inhibition of the enzyme PTP1B in a mammal for the treatment of diabetes.
    Type: Application
    Filed: October 6, 2016
    Publication date: May 11, 2017
    Applicant: Ohr Pharmaceutical, Inc.
    Inventors: Michael McLane, Inez Ruiz-White, W. Lee Maloy, Henry R. Wolfe
  • Patent number: 9546194
    Abstract: This application is directed to the use of aminosteroid compounds for the selective inhibition of the enzyme PTP1B in a mammal for the treatment of diabetes.
    Type: Grant
    Filed: April 19, 2013
    Date of Patent: January 17, 2017
    Assignee: Ohr Pharmaceutical, Inc.
    Inventors: Michael McLane, Inez Ruiz-White, W. Lee Maloy, Henry R. Wolfe
  • Publication number: 20160362444
    Abstract: This application is directed to the use of steroid compounds for the selective inhibition of the enzyme PTP1B in a mammal for the treatment of diabetes.
    Type: Application
    Filed: June 9, 2016
    Publication date: December 15, 2016
    Applicant: Ohr Pharmaceutical Inc.
    Inventors: Michael McLane, Inez Ruiz-White, Henry Wolfe
  • Patent number: 9365608
    Abstract: This application is directed to the use of steroid compounds for the selective inhibition of the enzyme PTP1B in a mammal for the treatment of diabetes.
    Type: Grant
    Filed: September 8, 2008
    Date of Patent: June 14, 2016
    Assignee: Ohr Pharmaceutical, Inc.
    Inventors: Michael McLane, Inez Ruiz-White, Henry Wolfe
  • Publication number: 20150099727
    Abstract: This application is directed to the use of aminosteroid compounds for the selective inhibition of the enzyme PTP1B in a mammal for the treatment of diabetes.
    Type: Application
    Filed: April 19, 2013
    Publication date: April 9, 2015
    Applicant: Ohr Pharmaceutical Inc.
    Inventors: Michael McLane, Inez Ruiz-White, W. Lee Maloy, Henry R. Wolfe
  • Publication number: 20100324004
    Abstract: This application is directed to the use of steroid compounds for the selective inhibition of the enzyme PTP1B in a mammal for the treatment of diabetes.
    Type: Application
    Filed: September 8, 2008
    Publication date: December 23, 2010
    Inventors: Michael McLane, Inez Ruiz-White, Henry Wolfe
  • Patent number: 7601487
    Abstract: A corneal storage solution which maintains cell density and cell viability of corneas stored in vitro for a period of greater than four days up to about two weeks is provided. The solution contains a buffered, balanced, nutrient and electrolyte aqueous solution, at least one colloidal osmotic agent, a phenolic antioxidant compound, a non-lactate-generating substrate, a thiol-containing compound, insulin, and at least one antibiotic. A method for in vitro storage and preservation of the viability of human corneal endothelial cells for subsequent use includes the steps of removing a cornea from an eye globe and placing the cornea in the above corneal storage solution.
    Type: Grant
    Filed: April 6, 2006
    Date of Patent: October 13, 2009
    Assignee: Cleo Cosmetic and Pharmaceutical Co., LLC
    Inventors: David B. Soll, Inez A. Ruiz-White, Teresita M. Smith